Strand Life Sciences Acquires India Diagnostics Business From Quest Diagnostics
October 6, 2018 | Bangalore Strand Life Sciences announced an agreement to acquire the India medical diagnostics business of Quest Diagnostics, the world’s leading provider
High Prevalence Of Hereditary Breast And/Or Ovarian Cancer Among Patients In India
A study conducted by Strand Life Sciences shows that in the Indian population, there is a high prevalence of germline mutations in the BRCA1, BRCA2, TP53 and PALB2 genes March 13,
Strand Life Sciences Closes Financing Led By Quadria Capital
February 8, 2018 | Bangalore Strand Life Sciences announced an investment by Quadria Capital, Asia’s leading healthcare focused private equity investor. India-based HealthQuad Fund and
Triesta Unit Of HCG To Combine With Strand Life Sciences
Strategic initiative creates integrated platform dedicated to next generation precision medicine January 4, 2018 | Bengaluru, India Healthcare Global Enterprises, Ltd. (HCG:NSE) today announced execution
Strand Press Releases
Strand In the News